Repeated administration of inorganic nitrate on blood pressure and arterial stiffness: a systematic review and meta-analysis of randomized controlled trials.

Dandan Li, Stephanie K Nishi, Elena Jovanovski, Andreea Zurbau, Allison Komishon, Sonia Blanco Mejia, Tauseef A Khan, John L Sievenpiper, Davor Milicic, Alexandra Jenkins, Vladimir Vuksan

Journal: Journal of hypertension 2021;38(11):2122-2140

PMID: 32723980

Abstract

OBJECTIVE

We aim to synthesize effects of repeated administration (≥3 days) of inorganic nitrate on blood pressure and arterial stiffness measures.

METHODS

We conducted a systematic review and meta-analysis of randomized controlled trials with at least 3 days treatment of inorganic nitrate on blood pressure and arterial stiffness in individuals with or without elevated cardiovascular disease risk. MEDLINE, EMBASE and the Cochrane Library were searched through 2 July 2019. Two independent reviewers extracted relevant study data. Data were pooled using the generic inverse variance method with random-effects model, and expressed as mean differences with 95% confidence intervals. Certainty in the evidence was assessed using GRADE.

RESULTS

Forty-seven trials were included (n = 1101). Administration of inorganic nitrate significantly lowered SBP [mean difference: -2.91 mmHg, 95% confidence interval (95% CI): -3.92 to -1.89, I = 76%], DBP (mean difference: -1.45 mmHg, 95% CI: -2.22 to -0.68, I = 78%], central SBP (mean difference: -1.56 mmHg, 95% CI: -2.62 to -0.50, I = 30%) and central DBP (mean difference: -1.99 mmHg, 95% CI: -2.37 to -1.60, I = 0%). There was no effect on 24-h blood pressure, augmentation index or pulse wave velocity. Certainty in the evidence was graded moderate for central blood pressure, pulse wave velocity and low for peripheral blood pressure, 24-h blood pressure and augmentation index.

CONCLUSION

Repeated administration (≥3 days) of inorganic nitrate lower peripheral and central blood pressure. Results appear to be driven by beneficial effects in healthy and hypertensive individuals. More studies are required to increase certainty in the evidence.

Address: Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital, Unity Health.; Department of Nutritional Sciences, Faculty of Medicine, University of Toronto.; Toronto 3D Knowledge Synthesis & Clinical Trials Unit.; Division of Endocrinology and Metabolism, Department of Medicine.; Li Ka Shing Knowledge Institute, St. Michael's Hospital.; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Internal Medicine and Cardiology, Rebro Clinic-Hospital, Faculty of Medicine, University of Zagreb, Zagreb, Croatia.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.